UA33665A - Method for intensive treatment of simple schizophrenia - Google Patents

Method for intensive treatment of simple schizophrenia

Info

Publication number
UA33665A
UA33665A UA99031605A UA99031605A UA33665A UA 33665 A UA33665 A UA 33665A UA 99031605 A UA99031605 A UA 99031605A UA 99031605 A UA99031605 A UA 99031605A UA 33665 A UA33665 A UA 33665A
Authority
UA
Ukraine
Prior art keywords
duration
intensive treatment
daily
haloperidol
simple schizophrenia
Prior art date
Application number
UA99031605A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Петро Тодорович Петрюк
Петр Тодорович Петрюк
Original Assignee
Харківська Міська Клінічна Психіатрична Лікарня № 15
Харьковская Городская Клиническая Психиатрическая Больница № 15
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харківська Міська Клінічна Психіатрична Лікарня № 15, Харьковская Городская Клиническая Психиатрическая Больница № 15 filed Critical Харківська Міська Клінічна Психіатрична Лікарня № 15
Priority to UA99031605A priority Critical patent/UA33665A/en
Publication of UA33665A publication Critical patent/UA33665A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the medicine, namely to the psychiatry. The method for the intensive treatment of the simple schizophrenia consists in increasing the daily dose of Haloperidol to high (by 2-4 mg daily up to 40 mg/day within one week). In 4 h after the oral administration of Haloperidol in the morning, the central analgesia follows in the varying relative pulse duration mode with the increment of the current from 0.8 to 1.2 mA, the pulse rate from 200 to 1000 Hz, their duration from 1.2 to 1.3 ms. The duration of the procedure increases from 45 to 60 min with the course of the treatment comprising 12 daily procedures.
UA99031605A 1999-03-23 1999-03-23 Method for intensive treatment of simple schizophrenia UA33665A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA99031605A UA33665A (en) 1999-03-23 1999-03-23 Method for intensive treatment of simple schizophrenia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA99031605A UA33665A (en) 1999-03-23 1999-03-23 Method for intensive treatment of simple schizophrenia

Publications (1)

Publication Number Publication Date
UA33665A true UA33665A (en) 2001-02-15

Family

ID=74197200

Family Applications (1)

Application Number Title Priority Date Filing Date
UA99031605A UA33665A (en) 1999-03-23 1999-03-23 Method for intensive treatment of simple schizophrenia

Country Status (1)

Country Link
UA (1) UA33665A (en)

Similar Documents

Publication Publication Date Title
GEP20053602B (en) Aripiprazole for Oral Administration
GEP20032965B (en) Pharmaceutical Compound
EP1708685A4 (en) Effervescent oral opiate dosage forms and methods of administering opiates
EP0740650A4 (en) Codrugs as a method of controlled drug delivery
MXPA02001306A (en) Pharmaceutical compositions for the treatment of cns and other discorders.
DE60134453D1 (en) Pharmaceutical compositions for the treatment of CNS and other diseases
GR3031448T3 (en) Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine.
ZA968808B (en) Production of analgesic synergy by co-administration of sub-analgesic doses of a mu opioid agoinst and a kappa-2 opioid agonist
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
TR199801164T2 (en) Substituted tetracyclic tetrahydrofuran derivatives.
GEP20022801B (en) Pyridazino [4,5-B]-Quinoline 5-Oxide Derivatives, Their Preparation and Their Use as Glycine Antagonists
WO2002056875A3 (en) Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance
GB9212308D0 (en) Therapeutic compositions
ATE102830T1 (en) METHOD OF TREATMENT OF INTERSTITIAL BLADDER INFLAMMATION.
ZA201106419B (en) Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid
IL136733A0 (en) Pharmaceutical composition containing sibutramine and orlistat
UA33665A (en) Method for intensive treatment of simple schizophrenia
MXPA01012936A (en) Pharmaceutical composition containing sibutramine and orlistat.
UA33739A (en) Method for treating continious schizophrenia
UA33655A (en) Method for treating simple and paranoid schizophrenia
UA33819A (en) Method for treating paranoid shift-like schizophrenia
JO2296B1 (en) Substituted pyrroles
MY133596A (en) Compound and method for the treatment of pain
UA38299A (en) METHOD OF INTENSIVE THERAPY OF DEPRESSIVE-PARANOID SYNDROME IN PATIENTS WITH SCHIZOPHRENIA
UA35608U (en) Method for intensive treatment of decompensations in patients with organic personality disorder and aggressiveness